TTN and heart failure: Surprisingly, we found that under baseline conditions and Ang II-induced heart failure, treatment with NALA caused significant increase in α-MHC K1897 lactylation and α-MHC–Titin interaction (Fig. 7e, f and Supplementary information, Fig. S7h).